Roivant Sciences Ltd. has grown revenue −36% a year over three years and −19% a year over five. Revenue growth, 3-year annual rate: −36% (Biotechnology median +21%). Revenue growth, 5-year rate: −19%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

ROIVRoivant Sciences Ltd.

HealthcareUSD

$36.77

$11.1752 weeks$37.41

Is it growing?

Is ROIV growing?

Roivant Sciences Ltd. has grown revenue −36% a year over three years and −19% a year over five.

−36%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −19%
Revenue growth, 5-year rate · −36% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›